# Magenta Therapeutics Inc. (MGTA)

Source: https://www.quantisnow.com/company/MGTA
Generated: 2026-11-20T17:07:41.783Z

- Ticker: MGTA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: magentatx.com

## About

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an antibody-drug conjugate program to prevent prophylaxis of graft-versus-host diseases. It has a has a research and clinical collaboration agreement with AVROBIO, Inc.to evaluate potential utility of MGTA-117 for conditioning of patients receiving one or more investigational lentiviral gene therapies; and clinical trial collaboration with bluebird bio, Inc. to evaluate the utility of MGTA-145, in combination with plerixafor, for mobilization and collection of stem cells in adults and adolescents with sickle cell disease. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

## Latest MGTA news and filings

- 2024-02-14 21:58 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-magenta-therapeutics-inc-amendment-5264677)
- 2024-02-14 21:16 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-magenta-therapeutics-inc-amendment-5263527)
- 2024-02-14 21:15 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-magenta-therapeutics-inc-amendment-5263494)
- 2024-02-09 21:10 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-magenta-therapeutics-inc-amendment-5246422)
- 2024-02-07 21:52 UTC [SEC Form S-1] [SEC Form S-1/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-1a-filed-by-magenta-therapeutics-inc-amendment-5238169)
- 2024-02-02 21:32 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-magenta-therapeutics-inc-5226947)
- 2024-01-31 17:11 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-magenta-therapeutics-inc-5219711)
- 2024-01-26 21:51 UTC [SEC Form 4] [SEC Form 4 filed by Carr Edward](https://www.quantisnow.com/insight/sec-form-4-filed-by-carr-edward-5211564)
- 2024-01-26 21:46 UTC [SEC Form 4] [SEC Form 4 filed by Veness Adam M](https://www.quantisnow.com/insight/sec-form-4-filed-by-veness-adam-m-5211543)
- 2024-01-26 21:43 UTC [SEC Form 4] [SEC Form 4 filed by Randhawa Simrat](https://www.quantisnow.com/insight/sec-form-4-filed-by-randhawa-simrat-5211526)
- 2024-01-26 21:41 UTC [SEC Form 4] [SEC Form 4 filed by Savitz Ryan](https://www.quantisnow.com/insight/sec-form-4-filed-by-savitz-ryan-5211517)
- 2024-01-26 21:36 UTC [SEC Form 4] [SEC Form 4 filed by Garcia Marino](https://www.quantisnow.com/insight/sec-form-4-filed-by-garcia-marino-5211479)
- 2024-01-25 00:04 UTC [SEC Form 4] [Moulder Leon O Jr was granted 166,667 shares (SEC Form 4)](https://www.quantisnow.com/insight/moulder-leon-o-jr-was-granted-166667-shares-sec-form-5205805)
- 2024-01-25 00:02 UTC [SEC Form 4] [Fairmount Funds Management Llc was granted 834,334 shares (SEC Form 4)](https://www.quantisnow.com/insight/fairmount-funds-management-llc-was-granted-834334-shares-sec-form-5205802)
- 2024-01-24 23:55 UTC [SEC Form 4] [Meng Lei was granted 1,500,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/meng-lei-was-granted-1500000-shares-sec-form-4-5205782)
- 2024-01-24 22:26 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-magenta-therapeutics-inc-amendment-5205632)
- 2024-01-22 12:34 UTC [SEC Form 8-K] [Magenta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/magenta-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5197440)
- 2024-01-08 13:02 UTC [SEC Form 8-K] [Magenta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/magenta-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5174991)
- 2023-12-21 22:08 UTC [SEC Form S-1] [SEC Form S-1/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-1a-filed-by-magenta-therapeutics-inc-amendment-5151714)
- 2023-12-21 21:16 UTC [SEC Form 8-K] [Magenta Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/magenta-therapeutics-inc-filed-sec-form-8-k-other-events-financial-5151348)
- 2023-11-13 14:02 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-magenta-therapeutics-inc-5079382)
- 2023-11-09 21:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-magenta-therapeutics-inc-5075294)
- 2023-11-09 21:09 UTC [SEC Form 8-K] [Magenta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/magenta-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5074959)
- 2023-10-25 20:15 UTC [SEC Form 8-K] [Magenta Therapeutics Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant](https://www.quantisnow.com/insight/magenta-therapeutics-inc-filed-sec-form-8-k-changes-in-registrants-5038017)
- 2023-10-04 20:55 UTC [SEC Form S-8] [SEC Form S-8 filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-magenta-therapeutics-inc-5005023)
- 2023-10-04 20:20 UTC [SEC Form S-3] [SEC Form S-3 filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-magenta-therapeutics-inc-5004670)
- 2023-10-03 20:00 UTC [Insider Buy] [Fairmount Funds Management Llc bought $336,252 worth of shares (24,670 units at $13.63) (SEC Form 4)](https://www.quantisnow.com/insight/fairmount-funds-management-llc-bought-336252-worth-of-shares-24670-5000660)
- 2023-09-28 21:09 UTC [Insider Buy] [Fairmount Funds Management Llc bought $394,500 worth of shares (30,000 units at $13.15) (SEC Form 4)](https://www.quantisnow.com/insight/fairmount-funds-management-llc-bought-394500-worth-of-shares-30000-4993421)
- 2023-09-25 20:15 UTC [Insider Buy] [SEC Form 4: Randhawa Simrat bought $52,800 worth of shares (4,000 units at $13.20)](https://www.quantisnow.com/insight/sec-form-4-randhawa-simrat-bought-52800-worth-of-shares-4986558)
- 2023-09-21 20:34 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-magenta-therapeutics-inc-4983000)
- 2023-09-21 20:32 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-magenta-therapeutics-inc-4982991)
- 2023-09-21 20:23 UTC [Insider Buy] [SEC Form 4: Fairmount Funds Management Llc bought $396,000 worth of shares (30,000 units at $13.20)](https://www.quantisnow.com/insight/sec-form-4-fairmount-funds-management-llc-bought-396000-worth-4982908)
- 2023-09-21 20:15 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-magenta-therapeutics-inc-4982844)
- 2023-09-21 20:15 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Magenta Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-magenta-therapeutics-inc-4982838)
- 2023-09-21 01:50 UTC [SEC Form 8-K] [Magenta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Other Events (Amendment)](https://www.quantisnow.com/insight/magenta-therapeutics-inc-filed-sec-form-8-k-results-of-operations-4981441)
- 2023-09-15 20:56 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Magenta Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-magenta-therapeutics-inc-amendment-4973794)
- 2023-09-14 01:56 UTC [SEC Form 4] [SEC Form 4 filed by Meng Lei](https://www.quantisnow.com/insight/sec-form-4-filed-by-meng-lei-4969992)
- 2023-09-14 01:31 UTC [SEC Form 3] [SEC Form 3: New insider Meng Lei claimed ownership of 1,217,554 shares](https://www.quantisnow.com/insight/sec-form-3-new-insider-meng-lei-claimed-ownership-of-4969985)
- 2023-09-14 01:25 UTC [SEC Form 4] [SEC Form 4 filed by Violin Jonathan](https://www.quantisnow.com/insight/sec-form-4-filed-by-violin-jonathan-4969981)
- 2023-09-14 01:17 UTC [SEC Form 4] [SEC Form 4: Fairmount Funds Management Llc bought $271,680 worth of shares (24,254 units at $11.20)](https://www.quantisnow.com/insight/sec-form-4-fairmount-funds-management-llc-bought-271680-worth-4969980)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MGTA
- Earnings history: https://www.quantisnow.com/earnings/MGTA
- Dividend history: https://www.quantisnow.com/dividends/MGTA
- Insider transactions: https://www.quantisnow.com/insiders/MGTA
- Options chain: https://www.quantisnow.com/options/MGTA
- SEC 8-K filings only: https://www.quantisnow.com/company/MGTA/8-k
- RSS and alerts for MGTA: https://www.quantisnow.com/docs/rss-feeds.md
